3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 1
4
Phase 3
2
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
14
Lymphoma
12
Lymphoma, Large B-Cell, Diffuse
11
Lymphoma, Non-Hodgkin
10
Lymphoma, Mantle-Cell
10
Lymphoma, Large-Cell, Immunoblastic
10
Lymphoma, Follicular
10
Burkitt Lymphoma
10
Leukemia, Myeloid, Acute
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Chronic-Phase
8
Leukemia
8
Congenital Abnormalities
8
Myelodysplastic Syndromes
7
Multiple Myeloma
7
Leukemia, Myeloid, Accelerated Phase
7
Myeloproliferative Disorders
6
Hodgkin Disease
6
Blast Crisis
6
Recurrence
5
Primary Myelofibrosis
5
Lymphoma, T-Cell, Cutaneous
5
Leukemia, Hairy Cell
5
Dendritic Cell Sarcoma, Interdigitating
5
Sezary Syndrome
4
Pdgfra-Associated Chronic Eosinophilic Leukemia
4
Neoplasms, Plasma Cell
4
Mycosis Fungoides
4
Leukemia, Neutrophilic, Chronic
4
Interventions
Carboplatin
4
Melphalan
3
Vincristine
2
Etoposide
2
etoposide phosphate
1
Watchful Waiting
1
Ursodeoxycholic Acid
1
Topotecan
1
Thiotepa
1
Saline Solution
1
Radiotherapy
1
Radiation
1
Photochemotherapy
1
Paclitaxel
1
Nitroglycerin
1
Neoadjuvant Therapy
1
Mesna
1
Leukapheresis
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Dexmedetomidine
1
Cytarabine
1
Cryotherapy
1
Chemotherapy, Adjuvant
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Retinoblastoma
×
Filgrastim
×
Clear all
NCT00980551
2017-03-03
RELRB1
Children's Hospital Medical Center, Cincinnati
Phase NA
Withdrawn